Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $27.0700 (-0.81%) ($26.2100 - $27.8400) on Fri. May. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.42% (three month average) | RSI | 60 | Latest Price | $27.0700(-0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.6% a day on average for past five trading days. | Weekly Trend | EDIT advances 4.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(62%) IWO(58%) ARKG(57%) XBI(55%) IBUY(54%) | Factors Impacting EDIT price | EDIT will decline at least -3.21% in a week (0% probabilities). VIXM(-29%) UUP(-15%) VXX(-13%) TBT(-6%) UNG(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.21% (StdDev 6.42%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
5 Day Moving Average | $27.95(-3.15%) | 10 Day Moving Average | $27.81(-2.66%) | 20 Day Moving Average | $26.41(2.5%) | To recent high | -10.1% | To recent low | 81.9% | Market Cap | $1.681b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |